GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » N4 Pharma PLC (STU:0GO) » Definitions » Short Percentage of Float

N4 Pharma (STU:0GO) Short Percentage of Float


View and export this data going back to 2021. Start your Free Trial

What is N4 Pharma Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of N4 Pharma's Short Percentage of Float

For the Drug Manufacturers - Specialty & Generic subindustry, N4 Pharma's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

N4 Pharma's Short Percentage of Float Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, N4 Pharma's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where N4 Pharma's Short Percentage of Float falls into.


N4 Pharma (STU:0GO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » N4 Pharma PLC (STU:0GO) » Definitions » Short Percentage of Float
Comparable Companies
LSE:HELD AQSE:APOL AQSE:ANA XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB BOM:532321 TSE:4507 HKSE:03692 VTRS TSE:4523 BOM:500124 XPAR:IPN
Traded in Other Exchanges
N4P.GB:UK N4P:UK
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Website
https://www.n4pharma.com
N4 Pharma PLC is the holding company for N4 UK. N4 UK is a specialist pharmaceutical company engaged in the development of nanoparticle silica delivery systems to improve the cellular delivery and potency of cancer treatments and vaccines. The company operated in one business segment, that of the development and commercialisation of medicines via its delivery system called Nuvec.

N4 Pharma (STU:0GO) Headlines

No Headlines